Free tool
FAERS Monitor: Betaseron
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 103471 or its brand name (Betaseron, Interferon Beta-1b). Reports on generic versions are filed under their own applications.
Reports
19,082
Serious
10,670
56% of reports
Hospitalization
4,228
Death reported
1,337
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- influenza like illness1,404
- multiple sclerosis relapse1,346
- injection site pain1,198
- fatigue1,197
- multiple sclerosis1,166
- injection site erythema978
- drug ineffective970
- pain855
- headache844
- injection site reaction842
- fall819
- depression815
- gait disturbance780
- pyrexia748
- death728
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 405 |
| 2005 | 535 |
| 2006 | 803 |
| 2007 | 1,200 |
| 2008 | 368 |
| 2009 | 502 |
| 2010 | 747 |
| 2011 | 1,162 |
| 2012 | 1,785 |
| 2013 | 1,656 |
| 2014 | 1,564 |
| 2015 | 1,381 |
| 2016 | 1,393 |
| 2017 | 1,291 |
| 2018 | 1,158 |
| 2019 | 986 |
| 2020 | 583 |
| 2021 | 400 |
| 2022 | 352 |
| 2023 | 322 |
| 2024 | 197 |
| 2025 | 176 |
| 2026 | 115 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,035,077 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| multiple sclerosisSignal | 1,166 | 27.5 | 26.0 | 29,118 |
| multiple sclerosis relapseSignal | 1,346 | 22.1 | 20.9 | 26,597 |
| influenza like illnessSignal | 1,404 | 19.1 | 18.2 | 23,763 |
| injection site reactionSignal | 842 | 13.6 | 12.8 | 9,763 |
| injection site erythemaSignal | 978 | 8.8 | 8.2 | 6,693 |
| gait disturbanceSignal | 780 | 4.5 | 4.2 | 2,135 |
| injection site painSignal | 1,198 | 4.3 | 4.1 | 3,084 |
| depressionSignal | 815 | 4.0 | 3.7 | 1,812 |
| fallSignal | 819 | 2.7 | 2.5 | 899 |
| pyrexiaSignal | 748 | 2.4 | 2.2 | 609 |
| fatigue | 1,197 | 1.7 | 1.6 | 354 |
| pain | 855 | 1.5 | 1.4 | 163 |
| headache | 844 | 1.5 | 1.4 | 137 |
| death | 728 | 0.9 | 0.9 | 4 |
| drug ineffective | 970 | 0.8 | 0.8 | 45 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.